This infographic explores the pressure biopharma executives feel to move patient support hub functions in-house.
A recent survey of biopharmaceutical executives uncovered motivations for insourcing patient support programs (PSP) versus outsourcing – and asked how executives view the efficacy of their current hub. While many hubs today are outsourced to a vendor, there are some exceptions where more biopharma companies are insourcing certain functions. Even if confidence in insourcing readiness is low now, collaborating with an experienced vendor that can support the evolution of your PSP may be best.
What are the pros and cons to each model, and how can the right hub vendor support as your strategy evolves?
Download the infographic to explore the future of patient support services. Topics include:
Offered Free by: BioPharma Dive's studioID and Cardinal Health
See All Resources from: BioPharma Dive's studioID and Cardinal Health